Cowen And Company »

Beneficient shares owned by Cowen And Company

Quarter-by-quarter ownership of Beneficient (BENFW) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Beneficient

Tip: Access up to 7 years of quarterly data

All positions including Beneficient held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beneficient by Cowen And Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5k 350k 0.01
2023-12-31 $3.5k 350k 0.01

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Coinbase Global Com Cl A (COIN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Avidity Biosciences Ord (RNA)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ptc Therapeutics I (PTCT)
Tarsus Pharmaceuticals (TARS)
Quanta Services (PWR)
Establishment Labs Holdings Ord (ESTA)
Stoke Therapeutics (STOK)
Protagonist Therapeutics (PTGX)
Apple (AAPL)
Fulcrum Therapeutics (FULC)
Sumitomo Mitsui Finl Group I Sponsored Adr (SMFG)

View all positions for Cowen And Company

Top funds holding Beneficient

Highbridge Capital Management
Citadel Advisors
MMCAP International Inc. SPC
Yakira Capital Management
Rivernorth Capital Management
LMR Partners
CVI Holdings
Goldman Sachs Group
Exos TFP Holdings
Exos Asset Management
Cowen And Company
Hudson Bay Capital Management
Tenor Capital Management
Context Capital Management
Q Global Advisors

View all funds holding Beneficient